Yongli He

发表

MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.

Cheng Huang, Cheng Huang, Jun Li, 2012, Cellular signalling.

Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study

Dong Wang, Yongli He, Yu-Mei Shi, 2022, The Lancet regional health. Western Pacific.

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

Cheng Huang, Xiao-ming Meng, Jun Li, 2014, Cancer letters.

Exploring biomarkers and therapeutic targets for pressure overload induced heart failure based on microarray data.

Zhe Feng, Yongli He, Cheng Huang, 2020, Cardiovascular diagnosis and therapy.

miR-21 is a Critical Therapeutic Target for Renal Fibrosis

Cheng Huang, Jun Li, Yongli He, 2014, Cell Biochemistry and Biophysics.

SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages.

Taotao Ma, Cheng Huang, Jun Li, 2014, Toxicology letters.

Ulinastatin Inhibits the Proliferation, Invasion and Phenotypic Switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP Signaling Pathway

Yongli He, Cheng Huang, Rui Wang, 2020, Drug design, development and therapy.

Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway.

Taotao Ma, Cheng Huang, Xiao-ming Meng, 2015, International immunopharmacology.

Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet’s disease

Cheng Huang, Jun Li, Yongli He, 2014, Rheumatology International.

MicroRNA‐338‐3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression

Zhe Feng, Yongli He, Cheng Huang, 2022, Journal of clinical laboratory analysis.

Fibroblast activation protein, a potential diagnostic and therapeutic target for cancer.

Cheng Huang, Jun Li, Yongli He, 2014, Human pathology.

The emerging role of Nemo-like kinase (NLK) in the regulation of cancers

Jun Li, Yongli He, Yang Yang, 2015, Tumor Biology.

MiR-146a Regulates IL-6 Production in Lipopolysaccharide-Induced RAW264.7 Macrophage Cells by Inhibiting Notch1

Cheng Huang, Jun Li, Yongli He, 2014, Inflammation.

Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.

Cheng Huang, Jun Li, Yongli He, 2013, Cellular signalling.

Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.

Taotao Ma, Cheng Huang, Jun Li, 2013, Cellular signalling.

Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis.

Taotao Ma, Cheng Huang, Xiao-ming Meng, 2014, Biochimica et biophysica acta.

MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.

Cheng Huang, Jun Li, Yongli He, 2014, International journal of oncology.

Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation

Taotao Ma, Cheng Huang, Yongli He, 2013, Molecular and Cellular Biochemistry.

miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Cheng Huang, Jun Li, Yongli He, 2013, Toxicology.

MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK).

Cheng Huang, Xiao-ming Meng, Yongli He, 2016, Current pharmaceutical design.

Amelioration of Experimental Autoimmune Uveitis by Leflunomide in Lewis Rats

Cheng Huang, Jun Li, Yongli He, 2013, PloS one.

The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases.

Taotao Ma, Cheng Huang, Jun Li, 2013, Cellular signalling.

Interleukin-21, a potential diagnostic and therapeutic target for systemic lupus erythematosus

Cheng Huang, Jun Li, Yongli He, 2014, Rheumatology International.

MicroRNA-21: a central regulator of fibrotic diseases via various targets.

Yongli He, Jun Li, Ying Huang, 2015, Current pharmaceutical design.

MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases.

Cheng Huang, Jun Li, Yongli He, 2013, Biochimie.

The potential of microRNAs in liver fibrosis.

Cheng Huang, Jun Li, Yongli He, 2012, Cellular signalling.

MiR-146a Regulates IL-6 Production in Lipopolysaccharide-Induced RAW264.7 Macrophage Cells by Inhibiting Notch1

Cheng Huang, Yongli He, Xiao-ran Long, 2013, Inflammation.

Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation

Taotao Ma, Cheng Huang, Jun Li, 2014, Molecular and Cellular Biochemistry.

miR-21 is a Critical Therapeutic Target for Renal Fibrosis

Cheng Huang, Jun Li, Yongli He, 2014, Cell Biochemistry and Biophysics.

The potential of microRNAs in liver fibrosis.

Cheng Huang, Jun Li, Yongli He, 2012, Cellular signalling.

Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.

Taotao Ma, Cheng Huang, Jun Li, 2013, Cellular signalling.

Epigenetic Repression of miR‐129‐2 in Cancer

Cheng Huang, Jun Li, Yongli He, 2014, Liver international : official journal of the International Association for the Study of the Liver.

GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway

Cheng Huang, Xiao-ming Meng, Yongli He, 2023, Hepatology.